Incline Therapeutics

Redwood City, United States Founded: 2009 • Age: 17 yrs Acquired By The Medicines Company
Hospital-focused specialty pharmaceuticals are developed for acute pain management.

About Incline Therapeutics

Incline Therapeutics is a Healthcare company based in Redwood City (United States) founded in 2009, and was acquired by The Medicines Company in December 2012. Hospital-focused specialty pharmaceuticals are developed for acute pain management. Incline Therapeutics has raised $43.94 million across 3 funding rounds from investors including Frazier Healthcare Partners, The Medicines Company and 5AM Ventures. Its focus areas include Life Sciences, Drug Delivery, Patches and Pain Management. Its legal entity is Incline Therapeutics, Inc. Its competitors include Flexion Therapeutics, Cara Therapeutics and Eliem Therapeutics; 3 of its 3 listed competitors have raised funding.

Company details

Incline Therapeutics was founded in 2009 in Redwood City, United States, as a developer of specialty pharmaceuticals targeted at hospital settings. Operations center on iontophoretic transdermal systems for opioid analgesia in postoperative care. The lead product, IONSYS, a needleless patient-controlled device, received approvals in the US and Europe but faced voluntary recall in Europe due to stability issues and was not commercialized in the US.

Key Metrics

Funding Insights of Incline Therapeutics

Incline Therapeutics has successfully raised a total of $43.94M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $21.5 million completed in September 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $43.94M
  • Total Rounds 3
  • Last Round Series B β€” $21.5M
  • First Round $440,000

    (Jan 2010)

  • Investors Count 6

All 3 funding rounds of Incline Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2011$21.5MSeries B––
–
Jun 2010$22MSeries B–Frazier Healthcare Partners, 5AM Ventures
–
Jan 2010$440,000Seed––
–
Valuation history

7 investors in total: 7 institutional.

Investors in Incline Therapeutics

Incline Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Frazier Healthcare Partners, The Medicines Company and 5AM Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Healthcare sector private equity investments are managed by the firm.
1991frazierhealthcare.comSeattle, United States
Venture capital fund backed incubator focused on the healthcare startups
5amventures.comSan Francisco, United States
Investments are made in US life sciences and energy companies.
technologypartners.comPalo Alto, United States
Private markets investment management with strategies in equity, credit, and secondary investments.
adamsstreetpartners.com
Direct secondary investments are made in private company shares.
saintscapital.comDenver, United States
Funding and expertise are provided for medical device development.
2017emvllp.comSan Jose, United States
Markets and developing drugs in areas of acute cardiovascular care, infectious disease care and perioperative care.
1996themedicinescompany.comParsippany Troy Hills, United States
Premium access

Investor details for Incline Therapeutics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Incline Therapeutics

4 dated milestones of Incline Therapeutics across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Incline Therapeutics is founded.
  2. Funding First funding round of $440K.
  3. Funding Latest funding round, Series B, of $21.5M.
  4. Exit Acquired by The Medicines Company.

Competitors of Incline Therapeutics

Incline Therapeutics has 3 listed competitors in our database, 3 of them funded. They include Flexion Therapeutics, Cara Therapeutics and Eliem Therapeutics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
flexiontherapeutics.com2007Woburn, United States$62M692
Developer of therapies for the treatment of musculoskeletal disorders
caratherapeutics.com2004New York, United States$51M79
Developer of therapeutics for pain relief and inflammatory diseases
eliemtx.com2018Boston, United States$171.3M30
Develops antibody-based treatments for autoimmune and inflammatory disorders.
Premium access

Detailed competitors of Incline Therapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Incline Therapeutics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Incline Therapeutics

Incline Therapeutics was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Incline Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.

Incline Therapeutics is a funded company, having raised a total of $43.94M across 3 funding rounds to date. The company's 1st funding round was a Seed of $440K, raised on Jan 2010.

Incline Therapeutics was founded in 2009 in Redwood City, United States, as a developer of specialty pharmaceuticals targeted at hospital settings. Operations center on iontophoretic transdermal systems for opioid analgesia in postoperative care. The lead product, IONSYS, a needleless patient-controlled device, received approvals in the US and Europe but faced voluntary recall in Europe due to stability issues and was not commercialized in the US.

Incline Therapeutics's top competitors include Flexion Therapeutics, Cara Therapeutics and Eliem Therapeutics.

Incline Therapeutics has 7 investors. Key investors include Frazier Healthcare Partners, The Medicines Company, 5AM Ventures, Technology Partners, and Adams Street Partners.

Incline Therapeutics operates through Incline Therapeutics, Inc..

Yes. Incline Therapeutics was acquired by The Medicines Company in December 2012.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available